From 1000000-5000000 achieved so.docVIP

 PAGE \* MERGEFORMAT 9 From 1000000-5000000 achieved so I travel from Shenzhen to Jilin, just to catch up with a rare heavy snow can be regarded as God gave me this southern end of the year in a ceremony of re-. Looked at the hands of hot data, although the indoor heating makes no sense out of the window of the cold, but the mood seems to fall into the ice-cold! Good old days of cigarette smoke has been the third root, and tobacco combustion of volatile aroma continuously stimulated my nerves. An annual sales of 40 million hypertensive Chinese patent medicines sold at the beginning of a rapid decline after the price increase hastily, especially in Heilongjiang, Jilin two markets, all from more than 300 million in annual sales slipped to 1.3 million! What is happening? Is a marketing resource allocation problem, or product positioning problem? Is a question of personnel arrangement, or price increases are Guards to act? Competitors interception, or the ruthless abandon the pharmaceutical business? Everything that has happened over the past year 11 flash. Board of Directors to the marketing departments and the time is limited, task is to complete the sale of marketing people’s vocation and raison d’etre! Jilin decline in the rate is too horrible. In 2006 anyway to reverse the situation, to the board submit a satisfactory answer ah. First, the plight of 1, the product price increase issue 30 years of high blood pressure sales of proprietary Chinese medicine has its unique effect of common people, a stable price (the retail price of 8 yuan / box), the old packaging has deep trust. Close to 30% price increase in 2005, the people not suited to, and not suited to the pharmacies, hospitals not meet, and not suited to traditional commerce, the market got a cold! The lack of strong price increases after the follow-up, the whole channel link has not kept pace with the speed of price increases. Solid price increases must be on the unconventional means of! 2, product